Eurofins Genomics Americas is a leading player in the genomics industry, offering a comprehensive range of high-quality products and services. The company specializes in synthetic DNA (oligonucleotides) with numerous modification options and an impressive turnaround time. Furthermore, it provides specialized long RNA oligos with a diverse range of modifications, gene synthesis services, Sanger sequencing with overnight results, and nanopore sequencing for various sample types. As part of Eurofins Scientific, Eurofins Genomics benefits from the support of over 14,000 staff and 180 laboratories across 35 countries, establishing a solid foundation for its operations. Additionally, Eurofins Scientific is a global leader in food and bio/pharma products testing, with a strong presence in the US and throughout the Americas. Overall, Eurofins Genomics Americas is a key player in the biotechnology, life sciences, and pharmaceutical industries, with a proven track record and solid backing from its parent company.
There is no investment information
No recent news or press coverage available for Eurofins Genomics Americas.